View in EDS

Neoadjuvant or adjuvant immunotherapy in bladder cancer: biological opportunity or clinical utility?

Saved in:
Bibliographic Details
Title: Neoadjuvant or adjuvant immunotherapy in bladder cancer: biological opportunity or clinical utility?
Authors: Petrelli F; Oncology Unit, ASST Bergamo Ovest, Treviglio (BG), Italy., Perego G; Pharmacy Unit, San Raffaele Hospital, Milano, Italy., Vavassori I; Urology Unit, ASST Bergamo Ovest, Treviglio (BG), Italy., Luciani A; Oncology Unit, ASST Bergamo Ovest, Treviglio (BG), Italy.
Source: Tumori [Tumori] 2022 Oct; Vol. 108 (5), pp. 510-511. Date of Electronic Publication: 2021 Nov 22.
Publication Type: Journal Article
Journal Info: Publisher: Sage Publications Country of Publication: United States NLM ID: 0111356 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2038-2529 (Electronic) Linking ISSN: 03008916 NLM ISO Abbreviation: Tumori Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34806495
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Neoadjuvant or adjuvant immunotherapy in bladder cancer: biological opportunity or clinical utility?
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Petrelli+F%22">Petrelli F</searchLink>; Oncology Unit, ASST Bergamo Ovest, Treviglio (BG), Italy.<br /><searchLink fieldCode="AU" term="%22Perego+G%22">Perego G</searchLink>; Pharmacy Unit, San Raffaele Hospital, Milano, Italy.<br /><searchLink fieldCode="AU" term="%22Vavassori+I%22">Vavassori I</searchLink>; Urology Unit, ASST Bergamo Ovest, Treviglio (BG), Italy.<br /><searchLink fieldCode="AU" term="%22Luciani+A%22">Luciani A</searchLink>; Oncology Unit, ASST Bergamo Ovest, Treviglio (BG), Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220111356%22">Tumori</searchLink> [Tumori] 2022 Oct; Vol. 108 (5), pp. 510-511. <i>Date of Electronic Publication: </i>2021 Nov 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage+Publications%22">Sage Publications </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0111356 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2038-2529 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203008916%22">03008916 </searchLink><i>NLM ISO Abbreviation: </i>Tumori <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34806495
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/03008916211061604
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 510
    Titles:
      – TitleFull: Neoadjuvant or adjuvant immunotherapy in bladder cancer: biological opportunity or clinical utility?
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Petrelli F
      – PersonEntity:
          Name:
            NameFull: Perego G
      – PersonEntity:
          Name:
            NameFull: Vavassori I
      – PersonEntity:
          Name:
            NameFull: Luciani A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2022 Oct
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2038-2529
          Numbering:
            – Type: volume
              Value: 108
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Tumori
              Type: main
ResultId 1